Cargando…
SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 receptor (ACE2) via the spike glycoprotein, followed...
Autores principales: | McGill, Andrew R., Kahlil, Roukiah, Dutta, Rinku, Green, Ryan, Howell, Mark, Mohapatra, Subhra, Mohapatra, Shyam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931091/ https://www.ncbi.nlm.nih.gov/pubmed/33557330 http://dx.doi.org/10.3390/idr13010013 |
Ejemplares similares
-
Activation of Intracellular Complement in Lungs of Patients With Severe COVID-19 Disease Decreases T-Cell Activity in the Lungs
por: Howell, Mark C., et al.
Publicado: (2021) -
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
por: Howell, Mark C., et al.
Publicado: (2021) -
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019) -
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021) -
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
por: Green, Ryan, et al.
Publicado: (2022)